[Construction history of bispecific antibodies and overview of its application for cancer immunotherapy].
Asano
Ryutaro
R
Department of Biomolecular Engineering, Graduate School of Engineering, Tohoku University, Sendai, Japan.
D018033:Antibodies, Bispecific / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy / Q000379:methods / Q000639:trends; D009369:Neoplasms / Q000628:therapy*; D015202:Protein Engineering / Q000639:trends; D011994:Recombinant Proteins
D018033:Antibodies, Bispecific; D011994:Recombinant Proteins